Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $122.15 USD
Change Today -4.15 / -3.29%
Volume 1.4M
As of 5:20 PM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Steven J. Burakoff M.D.

Member of Scientific Advisory Board, Vertex Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 57 board members in 3 different organizations across 4 different industries.

See Board Relationships
71--

Background*

Dr. Steven J. Burakoff, MD served as the Chairman of the Department of Pediatric Oncology at Dana-Farber Cancer Institute from 1985 to 2000. Dr. Burakoff has been a Director of Genzyme Corporation since June 2010. He serves as a Member of Scientific Advisory Board at Vertex Pharmaceuticals Incorporated. He serves as a Member of Cancer Center Advisory Board at St. Jude Children's Research Hospital, Inc. Dr. Burakoff served as a Director of Ligand Pharmaceuticals Incorporated ...

Read Full Background

Corporate Headquarters*

50 Northern Avenue
Boston, Massachusetts 02210

United States

Phone: 617-341-6100
Fax: --

Board Members Memberships*

2005-2008
Former Director and Member of Compensation Committee
2008-N/A
Former Director
2010-Present
Director, Member of Compensation Committee and Member of Risk Oversight Committee

Education*

BS
Lehigh University
MS
Harvard University
MD
Albany Medical College
Master's Degree
Queens College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRTX:US $122.15 USD -4.15

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$854.7K
Jean-Jacques Bienaime MBAChief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$916.0K
Robert W. Duggan Chairman and Chief Executive Officer
Pharmacyclics Inc.
--
Herve Hoppenot Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
Incyte Corporation
$2.9M
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$830.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERTEX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.